Japan's investment in India: post covid-19 investment opportunities in pharmaceuticals
India's import dependency for critical drug intermediates and active pharmaceutical ingredients (APIs) put questions on India's health and economic security. The quest for the solution lies in the self-sufficiency of the Indian pharmaceutical industry. Being a key investor, Japan appears t...
|Place of publication:||
|published in:||Transnational corporations review Vol. ahead-of-print; no. ahead-of-print; pp. 1 - 15|
|Data of publication:||//|
|Online Access:||available in Bonn?|
Database information Databases - DBIS